Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-11-005453
Filing Date
2011-08-04
Accepted
2011-08-04 15:20:33
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q hxbm_10q-063011.htm 10-Q 850656
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 17872
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 17946
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6345
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6357
  Complete submission text file 0001437749-11-005453.txt   3159602

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hxbm-20110630.xml EX-101.INS 483024
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hxbm-20110630.xsd EX-101.SCH 17986
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hxbm-20110630_cal.xml EX-101.CAL 30537
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hxbm-20110630_def.xml EX-101.DEF 85262
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hxbm-20110630_lab.xml EX-101.LAB 119424
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hxbm-20110630_pre.xml EX-101.PRE 98201
Mailing Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021
Business Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021 425 402 8400
HELIX BIOMEDIX INC (Filer) CIK: 0000831749 (see all company filings)

EIN.: 912099117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-20897 | Film No.: 111010301
SIC: 2834 Pharmaceutical Preparations